Latest News

  1. Press Release: QIAGEN launches fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

    NovelCD4/CD8 design delivers most comprehensive evaluation of patients’ immune response to tuberculosis infection.

  2. Press Release: QIAGEN’s QuantiFERON-TB Gold Plus gains U.S. FDA approval

    QIAGEN announces U.S. regulatory approval of QuantiFERON-TB Gold Plus (QFT-Plus) the fourth generation of the market leading blood test for detecting latent tuberculosis (TB) infection.

  3. Global Press Release: New research supporting QuantiFERON-TB Gold Plus

    This QIAGEN global press release describes new research studies suggesting the potential for additional clinical insights using QuantiFERON-TB Gold Plus.

Get in touch with QIAGEN
Follow QIAGEN on: